⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
globenewswire.com
OCS
Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026
globenewswire.com
OCS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Oculis Holding AG (OCS) And Encourages Investors to Connect
accessnewswire.com
OCS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
accessnewswire.com
OCS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
globenewswire.com
OCS
Bronstein, Gewirtz & Grossman, LLC Encourages Oculis Holding AG (OCS) Stockholders to Inquire about Securities Investigation
accessnewswire.com
OCS
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
globenewswire.com
OCS
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
globenewswire.com
OCS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
accessnewswire.com
OCS
Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference
globenewswire.com
OCS